The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBrand Architek. Regulatory News (BAR)

Share Price Information for Brand Architek. (BAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 27.50
Bid: 26.00
Ask: 29.00
Change: 0.00 (0.00%)
Spread: 3.00 (11.538%)
Open: 27.50
High: 27.50
Low: 27.50
Prev. Close: 27.50
BAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI)

20 May 2022 11:34

RNS Number : 2789M
Singer Capital Markets Sec Ltd
20 May 2022
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Singer Capital Markets Securities Ltd

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

BRAND ARCHITEKTS GROUP PLC

(c) Name of the party to the offer with which exempt principal trader is connected:

BRAND ARCHITEKTS GROUP PLC

(d) Date dealing undertaken:

19 May 2022

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

YES

If YES, specify which:

 

InnovaDerma PLC

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

ORD 5P

 

 

Sale

 

15,926

 

69p

 

69p

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

Date of disclosure:

20 May 2022

Contact name:

Sarah-Rose Perry, Jennifer Bentick

Telephone number:

020 7496 3093

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERURORRUUUVUAR
Date   Source Headline
17th Apr 20242:00 pmRNSHolding(s) in Company
2nd Apr 20245:35 pmRNSHolding(s) in Company
2nd Apr 20244:35 pmRNSHolding(s) in Company
25th Mar 20247:00 amRNSInterim results
15th Dec 202311:34 amRNSGrant of share options
14th Dec 202310:16 amRNSGrant and cancellation of share options
12th Dec 20234:02 pmRNSResult of AGM
1st Dec 20237:00 amRNSJoint Venture Settlement: Mr Haircare Limited
31st Oct 20237:00 amRNSFinal Results
19th Sep 20234:48 pmRNSBoard Responsibilities Update
20th Jul 20237:00 amRNSTrading Update & Resolution of Legal Claim
12th Jun 202310:30 amRNSGrant of Options
6th Jun 20237:00 amRNSBoard Responsibilities
31st May 20237:00 amRNSRule 19.6(c) confirmation
26th May 20237:00 amRNSDirectorate Changes
21st Mar 20237:00 amRNSInterim Results
24th Jan 20237:00 amRNSDirectorate Change & Trading Update
19th Dec 20224:24 pmRNSResult of AGM
28th Nov 20227:00 amRNSDirectorate Change
24th Nov 202211:50 amRNSAnnual Report and Accounts & Notice of AGM
16th Nov 202211:19 amRNSHolding(s) in Company
9th Nov 20225:00 pmRNSHolding(s) in Company
8th Nov 20225:16 pmRNSHolding(s) in Company
8th Nov 20227:00 amRNSFinal Results
27th Oct 20227:00 amRNSNotice of Results and Investor Presentation
25th Oct 202210:16 amRNSHolding(s) in Company
3rd Aug 20223:30 pmRNSHolding(s) in Company
3rd Aug 20229:21 amRNSHolding(s) in Company
3rd Aug 20229:19 amRNSHolding(s) in Company
21st Jul 20227:00 amRNSTrading Update
14th Jul 20227:00 amRNSHolding(s) in Company
4th Jul 202211:02 amRNSHolding(s) in Company
1st Jul 202211:44 amRNSHolding(s) in Company
30th Jun 20223:53 pmRNSHolding(s) in Company
30th Jun 20221:41 pmRNSHolding(s) in Company
16th Jun 20229:03 amRNSBoard Appointment
10th Jun 202212:35 pmRNSHolding(s) in Company
10th Jun 202212:10 pmRNSDirector/PDMR Shareholding
7th Jun 20224:34 pmRNSHolding(s) in Company
7th Jun 20224:28 pmRNSHolding(s) in Company
7th Jun 202211:51 amRNSHolding(s) in Company
7th Jun 202211:48 amRNSHolding(s) in Company
7th Jun 202211:47 amRNSHolding(s) in Company
31st May 20221:57 pmRNSScheme of Arrangement Becomes Effective
31st May 20229:52 amRNSForm 8.5 (EPT/RI)
30th May 202211:54 amRNSForm 8.5 (EPT/RI)
27th May 20224:01 pmRNSCourt Sanction of Scheme and Suspension
20th May 202211:34 amRNSForm 8.5 (EPT/RI)
19th May 20224:56 pmRNSResult of General Meeting
17th May 202212:03 pmRNSForm 8.5 (EPT/RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.